Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05924945 · ClinicalTrials.gov registry record · NA
Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms
A NA study, sponsored by Masimo Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT05924945 is a NA study that was terminated before completion, run by Masimo Corporation. The registered enrollment target is 13 participants.
The verdict
NCT05924945, a NA study, was terminated before completion, sponsored by Masimo Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this prospective study is to investigate the efficacy of the Bridge™ device in reducing the symptoms of opioid withdrawal in a blind comparison to a sham device.
Interventions
- DEVICE Bridge™ active device
- DEVICE Bridge™ sham device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2023-06-08 |
| Est. Completion | 2024-08-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05924945
The ClinicalTrials.gov registry entry for NCT05924945 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bridge™ active device is the first listed.
NCT05924945 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05924945 about?
NCT05924945 is a clinical study titled "Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms". The purpose of this prospective study is to investigate the efficacy of the Bridge™ device in reducing the symptoms of opioid withdrawal in a blind comparison to a sham device.
What is the current status of trial NCT05924945?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2023-06-08. Estimated completion is 2024-08-19.
What interventions are being tested in trial NCT05924945?
The interventions under investigation include: Bridge™ active device (DEVICE), Bridge™ sham device (DEVICE).
Who is sponsoring clinical trial NCT05924945?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.